As of November 6, 2026, BeOne Medicines Ltd. is a publicly traded company (Nasdaq: ONC). The largest holder reporting an active stake on Schedule 13D is Baker Bros. Advisors LP, at 7.8%. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13D/A, September 16, 2026).
Is this your company?
About to sign with, pay or invest in BeOne Medicines Ltd.? See the free Snapshot first.
Free to see. No signup.
Is BeOne Medicines Ltd. a real, registered company?
- BeOne Medicines Ltd. files with the SEC under CIK 1651308 (its SEC filings).
- Its shares are listed under the ticker ONC on Nasdaq (also BEIGF) (SEC company record).
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under BeOne Medicines Ltd. in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Baker Bros. Advisors LP (filed 2026-09-16).
Who are BeOne Medicines Ltd.'s owners and officers?
BeOne Medicines Ltd.: industry Pharmaceutical Preparations (Schedule 13D/A, 2026-09-16).
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-09-16 | Baker Bros. Advisors LP | 7.8% |
| Schedule 13D/A, 2026-06-15 | Baker Bros. Advisors LP | 8% |
| Schedule 13G/A, 2026-05-14 | Capital International Investors | 4.2% |
| Schedule 13D/A, 2026-04-16 | Baker Bros. Advisors LP | 8% |
Questions about who owns BeOne Medicines Ltd.
Who owns BeOne Medicines Ltd.?
On this page, one holder's latest ownership filing reports 5% or more of BeOne Medicines Ltd.: Baker Bros. Advisors LP (7.8%, Schedule 13D/A, filed 2026-09-16).
When did Baker Bros. Advisors LP buy into BeOne Medicines Ltd.?
The filings give report dates, not purchase dates. The earliest filing from Baker Bros. Advisors LP on this page is the Schedule 13D/A, filed 2026-04-16, reporting 8%; its latest, Schedule 13D/A filed 2026-09-16, reports 7.8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on BeOne Medicines Ltd.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on BeOne Medicines Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BeOne Medicines Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own BeOne Medicines Ltd. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- HHLR Advisors, Ltd., a 10% owner: 125,045,741 shares (8.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2024-12-04).
- Hillhouse Investment Management, Ltd., a 10% owner: 125,045,741 shares (8.4% of shares outstanding), held indirectly (the form names the holder only in its footnotes), on a joint filing (Form 4, 2024-12-04).
- , the chief executive and a director: 10,978,176 shares (0.74% of shares outstanding), 1,330,988 held directly and 9,647,188 indirectly (Form 4, 2026-08-12).
- Baker Brothers Life Sciences LP, a director: 8,281,566 shares (0.56% of shares outstanding), 20,837 held directly and 8,260,729 indirectly, on a joint filing (Form 4, 2026-09-16).
- , a director: 8,281,566 shares (0.56% of shares outstanding), 20,837 held directly and 8,260,729 indirectly, on a joint filing (Form 4, 2026-09-16).
Shares outstanding: 1,484,939,031 as of 2026-10-30, from the company's latest SEC cover page.
How much has BeOne Medicines Ltd. raised?
No fundraising or offering filing from BeOne Medicines Ltd. is on file with us.
Keep reading
More on BeOne Medicines Ltd. and the records around it.
BeOne Medicines Ltd. elsewhere on the record
- 5%+ stake filings Sep 2026
Companies that share a holder
- Baker Bros. Advisors LP also filed stake reports on 25 other companies: Madrigal Pharmaceuticals, Inc. (Nov 2026), Kodiak Sciences Inc. (Sep 2026), Cerus Corporation (Aug 2026)
- Capital International Investors also filed stake reports on 96 other companies: Aurora Innovation, Inc. (Nov 2026), Arxis, Inc. (Aug 2026), Astronics Corp. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/beone-medicines